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A B S T R A C T
O bjective : The etiology of microscopic and
macroscopic hematuria may range from 
conditions posing minimal risk to the patient to 
potentially life-threatening conditions. There are 
contraversial ideas about the evaluation of 
hematuria. In this survey, we examined the 
necessity of cystoscopy in patients with 
microscopic and macroscopic hematuria who 
were radiologically and microbiologically normal.
M ethods: A total of 139 patients with
microscopic or macroscopic hematuria who were 
microbiologically and radiologically normal and 
had cystoscopy between 1991 and 2003 were 
retrospectively analyzed. Routine history, 
physical examination, routine blood tests, urine 
analysis, urine culture, a plain radiography, 
urinary system ultrasonography / intravenous 
pyelography, computerized tomography and 
tuberculosis tests, including ARB-Bactec were 
unable to diagnose a pathology to identify the 
reason for hematuria, and cystoscopy was 
performed on all patients.
R e su lts : Seventy five (53.9%) patients were 
male and 64 (46.1%) were female. There was 
no pathology in 86 (61.8%) patients in 
diagnostic cystoscopy whereas, 21(15.2%) had 
a papillary tumor and 16 (11.5%) had a 
suspicious lesion in the bladder that was
biopsied. In 16 (11.5%) patients prostatic 
hypertrophy was the only cystoscopic finding. 
According to the histopathological examination, 
15 (93.5%) of the suspicious lesion biopsies 
were benign, but 1 (6.5%) patient had 
carcinoma in-situ. All of the papillary lesions 
were reported as superficial transitional cell 
carcinoma (TCCA). Overall, TCCA was detected 
in 4(4.9%) and 18(31%) patients with 
microscopic and macroscopic hematuria, 
respectively. Irrespective of the type of the 
hematuria, none of the patients under 40 years 
of age were found to have bladder cancer.
C o n c lu s io n : Our findings indicate that all 
patients older than 40 years of age with 
microscopic and macroscopic hematuria should 
undergo a cystoscopy. The current study further 
suggests that patients younger than 40 years of 
age with microscopic hematuria can only be 
safely followed up with non-invasive methods, 
without performing cystoscopy.
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IN T R O D U C T IO N
Hematuria is the presenting symptom in 85-90% 
of patients with bladder cancer; it may be gross
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or microscopic and intermittent or constant. It is 
mandatory to fully investigate such patients to 
exclude an underlying genitourinary malignancy
(1,2). The etiology of microscopic and 
macroscopic hematuria may range from 
conditions posing minimal risk to the patient, 
such as renal cyst, to potentially life-threatening 
conditions, predominantly including malignant 
tumors that must be distinguished from many 
other more common benign diseases (3). 
Macroscopic hematuria is common with a 
community prevalance of 2.5% (4) and estimated 
to account for 4% to 20% of all urological visits 
(5). Microscopic hematuria is a common clinical 
problem that has a 1% to 13% prevalence in 
adults (6).
There are contraversial ideas about the 
evaluation of hematuria that some authors 
reported such as: “hematuria of any degree 
should never be ignored, and in adults, it should 
be regarded as a symptom of urological 
malignancy until proven otherwise (7)” and 
“microscopic hematuria detected during a 
screening examination should probably not be 
regarded as a specific sign of a significant lesion 
and does not itself warrant urological 
investigation in adults aged 40 or less" (8). In the 
literature, the incidence of urogenital carcinoma 
in patients with microscopic hematuria is 
reported to range between 2.2% and 14.3%
(9,10).
The established urological evaluation of 
hematuria has undergone little change during the 
years and consists of urine analysis, urine 
culture, an upper urinary tract radiological study 
(intravenous pyelography (IVP) or urinary tract 
ultrasonography (USG)), tuberculosis tests, 
cytology and cystoscopy. As urological 
investigations fail to find the cause of isolated 
microscopic hematuria, an actual clinical problem 
for urologists is how extensively to evaluate 
young patients with microscopic hematuria in 
whom the incidence of malignancy is low. 
Cystoscopy which is one of the essential 
examinations in evaluation of hematuria can 
cause great discomfort to the patients and is an 
economic problem for both patients and 
government.
In this survey, we examined the necessity of 
cytoscopy in patients with microscopic and
macroscopic hematuria who were radiologically 
and microbiologically normal.
M ATERIAL A N D  METHODS
A total of 139 patients with microscopic or 
macroscopic hematuria who were 
microbiologically and radiologically normal and 
had cystoscopy between 1991 and 2003 were 
retrospectively analyzed. Microscopic hematuria 
is defined as, over 3 erytrocyte per high-power 
field in an urine sample. A routine history, physical 
examination, routine blood tests, urine analysis, 
urine culture, a plain radiography, urinary system 
ultrasonography / intravenous pyelography, 
computerized tomography and tuberculosis tests, 
including ARB-Bactec, were performed to all 
patients before cystoscopy. Computerized 
tomography without contrast medium was used in 
patients if a stone was suspected. These 
analyses were unable to indicate a pathology to 
identify the reason of hematuria. Persistent 
microscopic hematuria was defined as detected in 
minimum 3 urinalyses. All of the patients’ 
microscopic hematuria were persistent. 
Cystoscopy was performed under general 
anesthesia where the whole uretra, prostate, and 
bladder were screened for suspicious lesions and 
urine expulsion from ureteral orifices was 
observed. Any lesion found during cystoscopy 
was biopsied or resected. The specimens were 
analysed by the Department of Pathology at 
Marmara University. All of the patients had a 
minimum 1 year follow-up. The statistical analysis 
of the results was done by Q-square test.
RESULTS
The mean age of patients was 54.4 years (26- 
72). Seventy-five (53.9%) patients were male 
with a mean age of 54.5 years (26-72) and 64 
(46.1%) patients were female with a mean age
54.3 years (31-64).
Eighty-one (58.2%) patients were evaluated due 
to microscopic hematuria and 37 (45.7%) of 
these patients were male with a mean age of
54.5, on the other hand, the number of patients 
evaluated for macroscopic hematuria was 
58(41.8%). Thirty-eight (65.5%) patients of this 
group were male with a mean age of 54.5. The
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number of female patients for each group was 44 
(54.3%) and 20 (34.5%) with a mean age of 54.3 
for both groups, respectively (p=0.03).
When the patients were grouped according to 
age, 109 (78.4%) patients were >40 years and 30 
patients were <40 years of age. Microscopic 
hematuria was seen in 76.7% of patients <40 
years and 39.4% of patients >40 years of age, on 
the other hand, macroscopic hematuria was a 
symptom in 23.3% of patients <40 years and 
60.6% of patients >40 years (p=0.003). The 
demographic properties of the patients are 
summarized in table I.
T a b le  I: Relation between the type of hematuria, gender and
age.
Gender Age
Female 
No ot pts (n) 
(Percent (%))
Male
No ot pts (n) 
(Percent (%))
<40 years 
No ot pts (n) 
(Percent (%))
>40 years 
No ot pts (n) 
(Percent (%))
Microscopic
hematuria
44
(54.3%)
37
(45.7%)
23
(76.7%)
43
(39.4%)
Macroscopic
hematuria
20
(34.5%)
38
(65.5%)
7
(23.3%)
66
(60.6%)
Total
No of pts (n) 
(Percent (%))
64
(100%)
75
(100%)
30
(100%)
109
(100%)
* p=0,03 **p=0,003
Statistically significant difference between male and female patients in 
terms of the type of hematuria.
Statistically significant difference between the age groups in terms of the 
type of hematuria.
Cystoscopic findings of the patients are listed in 
table II. Cystoscopy detected no pathology in 86 
(61.8%) patients, whereas 21(15.2%) had a 
papillary lesion, 16(11.5%) had suspicious 
lesion that had been biopsied and 16(11.5%) 
patients had obstructive changes in the bladder 
due to BPH. As we subdivide the group 
according to the type of hematuria, 75.3% of 
patients with microscopic hematuria had entirely 
normal cystoscopy findings. This ratio was 
43.1% for patients with gross hematuria 
(p=0,001). A papillary lesion was detected in 
4.9% of patients with microscopic hematuria and 
29.3% of patients with macroscopic hematuria
(p=0.001).
The cystoscopic findings according to age group 
are listed in table II. There was no pathology on 
cystoscopy in 76.7% of patients younger than 40 
years and 57.8% of patients who were >40 years 
(p=0,04). None of the patients <40 years had 
papillary lesions on cystoscopy and 23.3% 
patients had suspicious lesios. In the patients 
over 40 years, 19.2% had a papillary lesion, 
8.3% had a suspicious lesion and 14.7% had 
obstructive changes in the bladder due to BPH
(p=0,02).
As a result, resection and biopsy performed to a 
total of 37 patients and 22 (15.8%) patients
Table II: The relation between the cystoscopic findigs, type of hematuria and age of patients.
No pathology 
No of pts (n) 
(Percent (%))
Papillary lesion 
No ot pts (n) 
(Percent (%))
Suspicious lesion 
No ot pts (n) 
(Percent (%))
Obstructive changes 
No ot pts (n) 
(Percent {%))
Total
No ot pts (n) 
(Percent (%))
Microscopic 61 4 6 7 81
hematuria (75.3%) (4.9%) (7.5%) (8.6%) •(100.0)
Macroscopic 25 17 10 9 58
hematuria (43.1%) (29.3%) (17.2%) (15.6%) ‘(100.0)
*p=0.001 ” p=0,001 ” * *p=0,12 * —  p=0,36
<40 years of 23 0 7 0 30
age (76.7%) (0.0%) (23.3%) (0.0%) (100.0%)
>40 years of 63 21 9 16 109
age (57.8%) (19.2%) (8.3%) (14.7%) (100.0%)
+p=0,04 ++p=0,02 +++p=0,06 ++++p=0,02
Total (n) 86 21 16 16 139
* Statistically significant difference between normal cystoscopic findings in terms of the type of hematuria.
“  Statistically significant difference between papillary lesions in cystoscopy in terms of the type of hematuria.
*** No statistically significant difference between suspicious lesions in cystoscopy in terms of the type of hematuria.
**** No statistically significant difference between obstructive changes in the bladder in terms of the type of hematuria.
+ Statistically significant difference between normal cystoscopic findings in terms of age groups.
++ Statistically significant difference between papillary lesions in cystoscopy in terms of age groups
+++ Statistically significant difference between suspicious lesions in cystoscopy in terms of age groups.
++++ Statistically significant difference between obstructive changes in the bladder in terms of age groups.
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indicated pathologically proven bladder tumor. 
The histopatological results are listed in table
III. All ot the papillary lesions were reported as 
transitional cell carcinoma. On the other hand, 
only 1 of 16 (6.2%) suspicious lesions was 
reported as carcinoma in-situ. All other biopsies 
were reported as benign lesions related to 
cystitis. Bladder tumor was diagnosed in 4 
(4.9%) patients with microscopic and 18 
(31.0%) patients with macroscopic hematuria 
(p=0.001).
When we analyzed the results according to age 
group, we observed that there was no bladder 
tumor in patients under 40 years of age. Indeed, 
all of the bladder tumors were observed in 
patients over 40 years of age (p=0,001). The age 
group of patients with bladder tumor was 45-72 
(mean:65).
The pathology of all bladder tumors was 
superficial. There was only one patient with 
carcinoma in-situ, who had admitted to our 
clinic with macroscopic hematuria. He was 62 
years of age. As we subdivide the tumor 
pathologies, 12 (57.1%) patients’ pathology 
was Ta and 9 (42.9%) patients’ pathology was 
T1 (p=0.25).
DISCUSSION
The value of cystoscopy in the evaluation of 
macroscopic hematuria is undebatable. The 
prevalance of bladder cancer with macroscopic 
hematuria was reported to be 22-35% (11,12). 
Indeed, most of these studies were designed to 
evaluate the prevalence of bladder tumor in the 
whole group of patients with macroscopic 
hematuria (whether radiologically or 
microbiologically normal or not). In the present 
study, we evaluated only patients with 
macroscopic hematuria who were radiologically 
and microbiologically normal and found a bladder 
tumor in 31% of patients. This result points out 
the necessity for cystoscopy in patients with 
macroscopic hematuria.
The crucial point of discussion is where and 
when we need cystoscopy in the evaluation of 
microscopic hematuria. Microscopic hematuria 
(symptomatic or asymptomatic) can be seen 
widely in urology clinics. Froom et al (8) found 
that 38.7% of young men between 18-33 years of 
age had microscopic hematuria at some point 
over a 15 year follow-up period. However, the 
prevalence of bladder cancer in patients with 
microscopic hematuria is much lower than in
T a b le  III: Relation between the pathologic diagnosis of patients and type of hematuria, age of patients and smoking.
Transitional Carcinoma Nonspecific Eosinophilic Total
cell carcinoma in-situ cystitis cystitis
No ot pts {n) No ot pts (n) No ot pts (n) No ot pts (n) No ot pts (n)
(Percent (%)) (Percent (%)) (Percent (%)) (Percent (%)) (Percent (%))
Microscopic 4 0 5 1 10
hematuria (40%) (10%) (50%) (10%) (100%)
Macroscopic 17 1 8 1 27
Hematuria (63.0%) (3.7%) (29.6%) (3.7%) (100%)
•p=0,001
<40 years of 0 0 7 1 8
age (0,0%) (0,0%) (87.5%) (12.5%) (100%)
>40 years of 21 1 6 1 29
age (72.5%) (3.4%) (20.7%) (3.4%) (100%)
” p=0,001
Non-smoker 6 1 5 2 14
(42.9%) (7.1%) (35.7%) (14.3%) (100%)
Smoker 15 0 8 0 23
(65.2%) (0.0%) (34.8%) (0.0%) (100%)
— p=0,28
Total 21 | 1 
____________________ I____________________
13
__ | 2
37
* Statistically significant difference between microscopic and macroscopic hematuria in terms of the incidence of bladder cancer. 
** Statistically significant difference oetween the age groups in terms of the incidence of bladder cancer.
*'* No statistically significant difference between cigarette smoking in terms of the incidence of bladder cancer.
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macroscopic hematuria which was reported as 
2.5% to 20% in population-based studies (13-
16). Khadra et al, found that the risk of bladder 
tumor in patients with macroscopic hematuria 
was 4 times greater than in microscopic 
hematuria and they reported the bladder cancer 
prevalence as 9.4% of 982 patients with 
microscopic hematuria (12). In another study, 
Suzuki et al reported 3% of patients with 
microscopic hematuria had bladder cancer (3). 
Britton et al (13) found 5.3% and Mayfield et al 
(16) found 5% prevalence for this group of 
patients. In our study, we found bladder cancer 
in 4.9 % of patients with microscopic hematuria 
who were radiologically and microbiologically 
normal (p=0,001). Therefore, other factors in 
patients with microscopic hematuria must be 
questioned before deciding on the need for 
cystoscopy.
Age seems to be an important factor for deciding 
on the need for cystoscopy in patients with 
hematuria. Thompson reported no malignancy in 
patients with microscopic hematuria who were 
under 40 years of age (17). In another study, 
Murakami et al, reported that all of the patients 
with bladder cancer found in cases with 
microscopic hematuria were older than 40 years
(18). Kupor and Topham proposed that patients 
aged <50 years and with microscopic hematuria 
could be managed with little or no urological 
investigation and should probably be referred for 
a nephrological opinion (19,20). The same 
results were also noted by Khadra et al.(12). In 
the present study we also did not detect any 
malignancy in patients <40 years of age. On the 
other hand, the youngest patient who had 
bladder cancer was 45 years old and the mean 
age of cancer patients was 65 years. There was 
a statistically significant difference between 
bladder cancer seen < 40 years and > 40 years 
of age (p=0,001). Therefore, cystoscopy Is 
necessary in patients older than 40 years, 
whether the hematuria is microscopic or 
macroscopic. On the other hand, for patients with 
microscopic hematuria, cystoscopy is more 
valuable for patients >40 years of age than 
patients < 40 years of age.
Cigarette smoking is a well known risk factor for 
bladder tumors. Grossfeld et al proposed that
cystoscopy for the evaluation of microscopic 
hematuria is recommended for all adults over 40 
years and for those under 40 years with risk 
factors for the development of bladder cancer 
such as a smoking history, occupational 
chemical exposure or history of irritative voiding 
symptoms (21). We also evaluated the relation 
between bladder tumors and cigarette smoking. 
Sixty eight percent of the patients who had 
bladder cancer were smokers. On the other 
hand, 58.6% of patients who had no bladder 
cancer were smokers. We could not find a 
significant relation between cigarette smoking 
and bladder cancer (p=0.28), but the number of 
patients was not high enough to allow an exact 
desicion on the subject.
Other questions to be answered are: 1- What 
happens to patients with microscopic hematuria 
who are cystoscopically normal during the follow­
up period? 2- Do we need to repeat cystoscopy 
after a period of follow-up? Studies showed that 
urologic malignancy was subsequently 
diagnosed In the follow-up of 1-3% of those with 
microscopic hematuria (18-22). Howard and 
Grolin, in a 10 to 20 year follow-up of 155 
patients with persistent hematuria showed that 
urothelial cancer did not develop in patients with 
a previous negative work-up (23). In our study 
group, we followed-up the patients for a median 
of 4 years (1-8 years). No pathological diagnosis 
was detected during the follow-up period. We 
propose to follow up the patients with 
unexplained microscopic hematuria with non- 
invasive methods.
Cystoscopy is still the most valuable diagnostic 
tool in patients with hematuria. However, it is an 
invasive and costly procedure which may be 
associated with morbidity related to anesthesia (if 
used), infection and endoscopic trauma. Our 
findings indicate that all patients older than 40 
years of age with unexplained microscopic or 
macroscopic hematuria should undergo a 
cystoscopy. The current study further suggests 
that patients younger than 40 years of age with 
an unexplained microscopic hematuria can only 
be safely followed up with non-invasive methods, 
without performing cystoscopy whereas 
macroscopic hematuria in this age group also 
warrants cystoscopic evaluation.
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